Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials.
Norton Succeeds Einhorn As ASCO President, Colorado’s Paul Bunn Is President-Elect.
Vermont Cancer Center’s NCI Core Grant Renewed.
Pharmacia Letter Announces Suspension Of Two Trials.
Medicare Expands Coverage for Lymphedema Pumps.
Newest NIH Institute, NIBIB, Gets An Acting Director.
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - Insights from ASCO 2025: Real-world evidence drives clinical decision-making
- In the Headlines: Missing record of NCAB meetings restored to NIH website
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”